Home
About
Overview
Sharing Data
ORCID
Help
History (31)
Trends in Enrollment, Clinical Characteristics, Treatment, and Outcomes According to Age in Non-ST-Segment-Elevation Acute Coronary Syndromes Clinical Trials.
Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial.
Being prepared: bioterrorism and mass prophylaxis: part I.
Co-occurring attention-deficit/hyperactivity disorder and anxiety disorders differentially affect males and females with autism.
TNF blockade enhances the efficacy of myxoma virus-based oncolytic virotherapy.
See All 31 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
TNF blockade enhances the efficacy of myxoma virus-based oncolytic virotherapy.
TNF blockade enhances the efficacy of myxoma virus-based oncolytic virotherapy. J Immunother Cancer. 2022 05; 10(5).
View in:
PubMed
subject areas
Humans
Inflammation
Interleukin-12
Myxoma virus
Oncolytic Virotherapy
Oncolytic Viruses
Tumor Necrosis Factor-alpha
authors with profiles
Eric Carter Bartee